Lyme Disease: A Review of Its Epidemiology, Evaluation, and Treatment

Psychosomatics

Volumn 55, Issue 5, 2014, Pages 421-429

  Gerstenblith, Ted Avi ^a,b   Stern, Theodore A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; DOXYCYCLINE; PENICILLIN DERIVATIVE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

AGE DISTRIBUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBIOTIC THERAPY; BRAIN TUMOR; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROMYALGIA; GUILLAIN BARRE SYNDROME; HEART; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IXODES; JOINT; LYME DISEASE; MEDICAL ASSESSMENT; MENTAL DISEASE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; REVIEW; RHEUMATOID ARTHRITIS; SEROLOGY; SKIN; SYPHILIS; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING; DIFFERENTIAL DIAGNOSIS; ENCEPHALITIS, TICK-BORNE; ENDEMIC DISEASE; NEUROIMAGING; UNITED STATES;

ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ENCEPHALITIS, TICK-BORNE; ENDEMIC DISEASES; HUMANS; LYME DISEASE; NEUROIMAGING; UNITED STATES;

EID: 84923817655     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2014.02.006     Document Type: Review

References (34)

1. Scrimenti R.J. Erythema chronicum migrans. Arch Dermatol 1970, 102:104-105.
2. Steere A.C., Malawista S.E., Snydman D.R., et al. Lyme arthritis: an epidemic of aoligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977, 20:7.
3. Steere A.C., Malawista S.E., Hardin J.A., et al. Erythema chronicum migrans and Lyme arthritis. Ann Intern Med 1977, 86:685-698.
4. Burgdorfer W., Barbour A.G., Hayes S.F., Benach J.L., Grunwaldt E., Davis J.P. Lyme disease-a tick-born spirochetosis?. Science 1982, 216(4552):1317-1319.
5. Centers for Disease Control (1991): Lyme disease surveillance: United States, 1989-1990; MMWR 40: 417-421.
6. Bacon R.M., Kugeler K.J., Mead P.S. Centers for Diseases Control and Prevention (CDC). Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ 2008, 57(10):1-9.
7. Bratton R.L., Whiteside J.W., Hovan M.J., Engle R.L., Edwards F.D. Diagnosis and treatment of Lyme disease. Mayo Clin Proc 2008, 83(5):566-571.
8. Edlow J.A. Diagnosing Lyme disease: getting the details right. Arch Intern Med 2012, 172(21):1625-1626.
9. Dandache P., Nadelman R.B. Erythema migrans. Infect Dis Clin North Am 2008, 22(2):235-260.
10. Wright W.F., Riedel D.J., Talwani R., Gilliam B.L. Diagnosis and management of Lyme disease. Am Fam Physician 2012, 85(11):1086-1093.
11. Henry B., Crabtree A., Roth D., Blackman D., Morshed M. Lyme disease: knowledge, beliefs, and practices of physicians in a low-endemic area. Can Fam Physician 2012, 58:289-295.
12. Hu L.T. Lyme Disease. Ann Intern Med 2012, 157:ITC2-1.
13. Brown S.L., Hansen S.L., Langone J.J. Role of serology in the diagnosis of Lyme disease. J Am Med Assoc 1999, 281(1):62-66.
14. Aguero-Rosenfeld M.E. Lyme disease: laboratory issues. Infect Dis Clin North Am 2008, 22(2):301-313.
15. Radolf J., Caimano M., Stevenson B., Hu L. Of ticks, mice, and men: understanding the dual-host lifestyle of Lyme disease spirochetes. Nat Rev Microbiol 2012, 10:87-99.
16. Bransfield R. The psychoimmunology of Lyme/tick-borne diseases and its association with neuropsychiatric symptoms. Open Neurol J 2012, 6:88-93.
17. Fallon B., Nields J., Burrascano J., Liegner K., DelBene D., Liebowitz M. The neuropsychiatric manifestations of Lyme borreliosis. Psychiatr Q 1992, 63(1):95-116.
18. Logigian E.L., Johnson K.A., Kijewski M.F., et al. Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology 1997, 49:1661.
19. Fallon B.A., Das S., Plutchok J., Tager F., Liegner K., Van Heertum R. Functional brain imaging and neuropsychological testing in Lyme disease. Clin Infect Dis 1997, 25(1):S57-S63.
20. Rachman M., Garfield D. Lyme disease and secondary depression: universal lessons from an uncommon case. Psychosomatics 1998, 39:301-302.
21. Westervelt H.J., McCaffrey R.J. Neuropsychological functioning in chronic Lyme disease. Nerve 2002, 12(3):153-177.
22. Wormser G.P., Dattwyler R.J., Shapiro E.D. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1089-1134.
23. Steere A. Reinfection versus relapse in Lyme disease. N Engl J Med 2012, 367:20.
24. Steere A., Taylor E., McHugh G., Logigian E. The overdiagnosis of Lyme disease. J Am Med Assoc 1993, 269(14):1812-1816.
25. Seltzer E.G., Gerber M.A., Cartter M.L., Freudigman K., Shapiro E.D. Long-term outcomes of persons with Lyme disease. J Am Med Assoc 2000, 283(5):609-616.
26. Hassett A.L., Radvanski D.C., Buyske S., Savage S.V., Sigal L.H. Psychiatric comorbidity and other psychological factors in patients with chronic Lyme disease. Am J Med 2009, 122:843-850.
27. Bujak D.I., Weinstein A., Dornbush R.L. Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 1996, 23:1293-1297.
28. Klempner M.S., Hu L.T., Evans J., et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001, 345:85-92.
29. Kaplan R.F., Trevino R.P., Johnson G.M., et al. Cognitive function in post-treatment Lyme disease. Do additional antibiotics help?. Neurology 2003, 60:1916-1922.
30. Feder H.M., Johnson B.J., O'Connell S. A critical appraisal of chronic Lyme disease. N Engl J Med 2007, 357:1422-1430.
31. Nadelman R.B., Hanincova K., Mukherjee P., et al. Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med 2012, 367:1883-1890.
32. Auwaerter P.G., Bakken J.S., Dattwyler R.J., et al. Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis 2011, 11:713-719.
33. Solomon S.P., Hilton E., Weinschel B.S., Polack S., Grolnick E. Psychological factors in the prediction of Lyme disease course. Arthritis Care Res 1998, 11:419-426.
34. Abbass A.A., Kisely S., Kroenke K. Short-term psychodynamic psychotherapies for somatic symptom disorders. Systemic review and metaanalysis. Psychother Psychosom 2009, 78:265-274.